融合MRI与O-(2-[18F]氟乙基)-L-酪氨酸(FET)PET显像所示肿瘤体积背景下室管膜下区受累对多形性胶质母细胞瘤的预后价值
35例多形性胶质母细胞瘤患者在放疗前接受双时间点FET PET/CT与MRI检查以定义肿瘤体积和室管膜下区受累,评估其与无进展生存和总生存的关系。双时间点FET PET检出室管膜下区浸润的比例高于MRI(60% vs 51%,p=0.25)且与较差生存显著相关(p<0.03),但该组PET-T1-Gad体积更大(p<0.002);多因素分析中融合PET-T1-Gad体积与KPS显著。作者认为基于FET PET的肿瘤体积可能有助于预测较差预后,但双时间点FET PET参数和室管膜下区浸润作为放疗前独立预后标志物的价值尚未被证实。
要点
- 双时间点FET PET检出室管膜下区浸润的比例高于MRI(60% vs 51%,p=0.25),差异未达统计学显著。
- 室管膜下区浸润与较差生存显著相关(p<0.03),但该组PET-T1-Gad体积更大(p<0.002)。
- 多因素分析中融合PET-T1-Gad体积与KPS显著(p<0.03),摄取动力学与治疗结局无关。
核心结论
- 作者认为基于FET PET的肿瘤体积可能有助于预测多形性胶质母细胞瘤的较差预后。
- 尽管室管膜下区浸润与较高的PET/MRI肿瘤体积相关,但双时间点FET PET参数和室管膜下区浸润作为放疗前独立预后标志物的价值尚未被证实。
研究设计与样本
- 35例患者在开始放疗前接受两次扫描,分别于静脉注射FET后5-15分钟和50-60分钟进行,以定义肿瘤体积和室管膜下区受累。
- 采用单变量和多变量分析评估临床进展标志物、基于MRI和双时间点FET PET的肿瘤体积、室管膜下区受累与无进展生存和总生存的关系。
主要发现
- 切除范围与结局无关。
- 双时间点FET PET检出室管膜下区浸润的比例高于MRI(60% vs 51%,p=0.25),差异未达统计学显著。
- 室管膜下区浸润与较差生存显著相关(p<0.03),但该组PET-T1-Gad体积更大(p<0.002)。
- MRI肿瘤体积较大、PET肿瘤体积较大及Karnofsky体能状态较差的患者生存更短,多因素分析中融合PET-T1-Gad体积与KPS显著(p<0.03)。
- 摄取动力学与治疗结局无关。
关键数值与推荐
- 双时间点FET PET检出室管膜下区浸润60% vs MRI 51%(p=0.25)。
- 室管膜下区浸润与较差生存相关(p<0.03),该组PET-T1-Gad体积更大(p<0.002)。
- 多因素分析中融合PET-T1-Gad体积与KPS显著(p<0.03)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 双时间点FET PET参数和室管膜下区浸润作为放疗前独立预后标志物的价值尚未被证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subventricular zone (SVZ) involvement is associated with a dismal prognosis in patients with glioblastoma multiforme (GBM). Dual-time point (dtp) O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET/CT (PET) may be a time- and cost-effective alternative to dynamic FET PET, but its prognostic value, particularly with respect to SVZ involvement, is unknown. METHODS: Thirty-five patients had two scans 5-15 and 50-60 min after i.v. FET injection to define tumor volumes and SVZ involvement before starting radiotherapy. Associations between clinical progression markers, MRI- and dtp FET PET-based tumor volumes, or SVZ involvement and progression-free (PFS) and overall survival (OS) were assessed in univariable and multivariable analyses. RESULTS: The extent of resection was not related to outcomes. Albeit non-significant, dtp FET PET detected more SVZ infiltration than MRI (60% vs. 51%, p = 0.25) and was significantly associated with poor survival (p < 0.03), but PET-T1-Gad volumes were larger in this group (p < 0.002). Survival was shorter in patients with larger MRI tumor volumes, larger PET tumor volumes, and worse Karnofsky performance status (KPS), with fused PET-T1-Gad and KPS significant in multivariable analysis (p < 0.03). Uptake kinetics was not associated with treatment outcomes. CONCLUSIONS: FET PET-based tumor volumes may be useful for predicting worse prognosis glioblastoma. Although the presence of SVZ infiltration is linked to higher PET/MRI-based tumor volumes, the independent value of dtp FET PET parameters and SVZ infiltration as prognostic markers pre-irradiation has not been confirmed.
引用
- Harat M, Małkowski B, Roszkowski K, et al. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) PET imaging in glioblastoma multiforme. Radiat Oncol. 2019. PMID: 30832691. doi:10.1186/s13014-019-1241-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。